Sunday 18 October 2026
Export CYAD’s income statement to Excel — free account
Celyad SA
CYAD Healthcare Biotechnology
Celyad SA’s revenue for fiscal 2025 (year ended December 2025) was $23,800.00, down 88.2% from fiscal 2024.
Follow CYAD
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Older periods | Jun '23 | Jun '24 | Jun '25 | Jun '26 | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
+8 more quarters Free account |
5.43 | 6.71 | 0.90 | 0.14 |
Receivables |
2.29 | 1.08 | 0.79 | 0.81 | |
Inventory |
— | — | 0.29 | 0.03 | |
Other current assets |
0.68 | 1.54 | 0.81 | 0.04 | |
Total current assets |
8.39 | 9.33 | 2.79 | 1.01 | |
Property, Plant, Equpment (Net) |
0.92 | 1.80 | 1.52 | — | |
Long-term receivables |
3.03 | 2.10 | 1.67 | 1.64 | |
Goodwill and Intangible Assets (Total) |
0.70 | 0.49 | 0.41 | 0.02 | |
Long-term assets (Other) |
0.23 | 0.12 | 0.09 | 0.04 | |
Total non-current assets |
4.89 | 4.50 | 3.68 | 1.69 | |
Total Assets |
13.28 | 13.83 | 6.47 | 2.70 | |
Accounts Payable |
3.72 | 1.14 | 1.05 | 0.25 | |
Current Part of Capital Lease |
0.20 | 0.17 | 0.09 | — | |
Other current liabilities |
2.72 | 1.29 | 3.09 | 0.83 | |
Total current liabilities |
6.64 | 2.60 | 4.22 | 1.08 | |
Long Term Debt (Total) |
0.38 | 0.90 | 0.86 | — | |
Pension and Post-Retirement Liabilities |
0.01 | 0.00 | 0.00 | — | |
Non-current Liabilities (Other) |
5.13 | 6.82 | 4.91 | 0.16 | |
Total non-current liabilities |
5.53 | 7.72 | 5.77 | 0.16 | |
Total liabilities |
12.17 | 10.32 | 9.99 | 1.24 | |
Additional Paid In Capital |
6.89 | — | — | — | |
Common Stock (Net) |
85.69 | 8.85 | 9.33 | 10.67 | |
Retained Earnings |
(385.66) | (389.21) | (417.61) | (423.89) | |
Shareholders Equity (Other) |
294.19 | 383.88 | 404.76 | 414.68 | |
Common Equity (Total) |
1.11 | 3.52 | (3.52) | 1.46 | |
Shareholders Equity (Total) |
1.11 | 3.52 | (3.52) | 1.46 | |
Shareholders Equity and Liabilities (Total) |
13.28 | 13.83 | 6.47 | 2.70 | |
Shares (Common) |
— | 41.43 | 41.43 | 44.76 | |
Shareholders Equity (Tangible) |
0.41 | 3.03 | (3.93) | 1.45 | |
Net Debt |
(5.04) | (5.81) | (0.04) | (0.14) | |
Total Debt |
0.38 | 0.90 | 0.86 | — |
In millions of $ except per-share values · columns are period end dates · fundamentals updated 14 Oct 2026